Effect of medical therapy on survival of patients with dilated cardiomyopathy (Q36531828)

14 August 2017

1 reference

title

Effect of medical therapy on survival of patients with dilated cardiomyopathy (English)

1 reference

14 August 2017

Calvert CA

1

1 reference

14 August 2017

publication date

1 September 1991

1 reference

Veterinary Clinics of North America: Small Animal Practice

14 August 2017

published in

1 reference

14 August 2017

volume

21

1 reference

14 August 2017

issue

5

1 reference

14 August 2017

page(s)

919-930

1 reference

Afterload reduction: a comparison of captopril and nifedipine in dilated cardiomyopathy

14 August 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Are beta-adrenergic-blocking drugs useful in the treatment of dilated cardiomyopathy?

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Cardiotonic activity of amrinone--Win 40680 [5-amino-3,4'-bipyridine-6(1H)-one]

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Intermittent, continuous outpatient dobutamine infusion in the management of congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Long-term digitalis therapy improves left ventricular function in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Survival of patients with severe congestive heart failure treated with oral milrinone

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Digitalis intoxication. A prospective clinical study with serum level correlations

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Hemodynamic assessment of amrinone. A new inotropic agent

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Effect of digitalis treatment on survival after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Decreased Catecholamine Sensitivity and β-Adrenergic-Receptor Density in Failing Human Hearts

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Effects of sodium nitroprusside on left ventricular diastolic pressure-volume relations

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

A placebo-controlled trial of captopril in refractory chronic congestive heart failure. Captopril Multicenter Research Group

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

CATECHOLAMINE EXCRETION AND CARDIAC STORES OF NOREPINEPHRINE IN CONGESTIVE HEART FAILURE

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Augmentation of the plasma nor-epinephrine response to exercise in patients with congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Effects of enalapril in heart failure: a double blind study of effects on exercise performance, renal function, hormones, and metabolic state

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Effect of vasodilator therapy on mortality in chronic congestive heart failure. Results of a Veterans Administration Cooperative Study

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Long-term therapy of heart failure with prazosin: a randomized double blind trial

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Symptomatic assessment of patients with heart failure: double-blind comparison of increasing doses of diuretics and captopril in moderate heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Maintenance Digoxin in Elderly Patients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Effects of nitroglycerin on left ventricular cavitary size and cardiac performance determined by ultrasound in man.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Oral amrinone for the treatment of chronic congestive heart failure: results of a multicenter randomized double-blind and placebo-controlled withdrawal study

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Maintenance digoxin after an episode of heart failure: placebo-controlled trial in outpatients

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Clinical assessment and follow-up of functional capacity in patients with chronic congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Effect of chronic oral digoxin therapy on ventricular function at rest and peak exercise in patients with ischemic heart disease

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Assessment of vasodilator therapy in patients with severe congestive heart failure: Limitations of measurements of left ventricular ejection fraction and volumes

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Is digoxin really important in treatment of compensated heart failure? A placebo-controlled crossover study in patients with sinus rhythm

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Rationale for beta-adrenergic blocking drugs in cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Hemodynamic effects of vasodilators and long-term response in heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Lack of correlation between exercise capacity and indexes of resting left ventricular performance in heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Hydralazine in the long-term treatment of chronic heart failure: lack of difference from placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Effect of vasodilators on survival in chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Double-blind trial of chronic oral beta blockade in congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Is maintenance digoxin necessary in patients with sinus rhythm?

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Clinical experience with amrinone in patients with advanced congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Left ventricular dynamics during long-term digoxin treatment in patients with stable coronary artery disease

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Hemodynamic comparison of intravenous amrinone and dobutamine in patients with chronic congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Controlled trial of captopril in chronic heart failure: a rest and exercise hemodynamic study

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Intermittent, ambulatory dobutamine infusions in patients with severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Heart failure in outpatients: a randomized trial of digoxin versus placebo

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Mechanisms of membrane-receptor regulation. Biochemical, physiological, and clinical insights derived from studies of the adrenergic receptors

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Amrinone therapy for congestive heart failure in outpatients with idiopathic dilated cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Improved exercise capacity and differing arterial and venous tolerance during chronic isosorbide dinitrate therapy for congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

The cardiovascular effects of the continuous infusion of dobutamine in patients with severe cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Sustained beneficial effects of oral amrinone on cardiac and renal function in patients with severe congestive heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Amrinone: a new non-glycosidic, non-adrenergic cardiotonic agent effective in the treatment of intractable myocardial failure in man

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Amrinone in the treatment of chronic cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

The role of cyclic AMP in isoprenaline-induced cardiac necroses in the rat.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Long-term oral administration of amrinone for congestive heart failure: lack of efficacy in a multicenter controlled trial

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Lack of relationship between the short-term hemodynamic effects of captopril and subsequent clinical responses

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Digitalis-associated cardiac mortality after myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Digoxin therapy and mortality after myocardial infarction. Experience in the MILIS Study

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Favorable effects of orally administered digoxin on left heart size and ventricular wall motion in patients with previous myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

How should we judge the efficacy of drug therapy in patients with chronic congestive heart failure? The insights of six blind men

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Vasodilator and inotropic therapy for severe chronic heart failure: Passion and skepticism

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Comparative hemodynamic and clinical effects of long-term treatment with prazosin and captopril for severe chronic congestive heart failure secondary to coronary artery disease or idiopathic dilated cardiomyopathy.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Role of the renin-angiotensin system in the development of hemodynamic and clinical tolerance to long-term prazosin therapy in patients with severe chronic heart failure.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Hemodynamic and clinical limitations of long-term inotropic therapy with amrinone in patients with severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Hemodynamic patterns of response during long-term captopril therapy for severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Importance of left ventricular chamber size in determining the response to hydralazine in severe chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Should digoxin be the drug of first choice after diuretics in chronic congestive heart failure?

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Effects of ouabain on impaired left ventricular function during convalescence after acute myocardial infarction

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Double-blind comparison of captopril alone against frusemide plus amiloride in mild heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

The effects of digitalis on survival in high-risk patients with coronary artery disease. The Coronary Artery Surgery Study (CASS).

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Enalapril in patients with chronic heart failure: a placebo-controlled, randomized, double-blind study

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Acute substantial benefit of inotropic therapy with amrinone on exercise hemodynamics and metabolism in severe congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Blind study on the action of digitoxin on elderly women

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Adverse effects of beta-blockade withdrawal in patients with congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Beneficial effects of long-term beta-blockade in congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Prolongation of survival in congestive cardiomyopathy by beta-receptor blockade

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Effects of enalapril on mortality in severe congestive heart failure. Results of the Cooperative North Scandinavian Enalapril Survival Study (CONSENSUS).

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Plasma norepinephrine in congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

The hemodynamic and metabolic advantages gained by a three-day infusion of dobutamine in patients with congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Long-term benefit of dobutamine in patients with congestive cardiomyopathy

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Effect of Digoxin on Ejection Fraction in Elderly Patients with Congestive Heart Failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Recent advances in knowledge about beta-adrenergic receptors: application to clinical cardiology

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Amrinone and exercise performance in patients with chronic heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Low-dose beta blockade in the treatment of chronic cardiac failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Exercise intolerance in patients with chronic left heart failure: relation to oxygen transport and ventilatory abnormalities

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Oral amrinone in refractory congestive heart failure

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

Digitalis--a new controversy regarding an old drug. The pitfalls of inappropriate methods.

1 reference

https://api.crossref.org/works/10.1016%2FS0195-5616%2891%2950103-0

7 January 2021

10.1016/S0195-5616(91)50103-0

Identifiers

DOI

1 reference

14 August 2017

1 reference